• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血小板衍生生长因子α受体介导的细胞反应在内皮细胞中不依赖于Src家族激酶。

PDGF alpha-receptor mediated cellular responses are not dependent on Src family kinases in endothelial cells.

作者信息

Hooshmand-Rad R, Yokote K, Heldin C H, Claesson-Welsh L

机构信息

Ludwig Institute for Cancer Research, Box 595, Biomedical Center, S-751 24 Uppsala, Sweden.

出版信息

J Cell Sci. 1998 Mar;111 ( Pt 5):607-14. doi: 10.1242/jcs.111.5.607.

DOI:10.1242/jcs.111.5.607
PMID:9454734
Abstract

Two novel autophosphorylation sites in the juxtamembrane region of the PDGF alpha-receptor, Tyr-572 and Tyr-574, were identified. A Y572/574F mutant PDGF (alpha)-receptor was generated and stably expressed in porcine aortic endothelial cells. In contrast to the wild-type receptor, the mutant receptor was unable to associate with or activate Src family tyrosine kinases. Tyrosine phosphorylated synthetic peptides representing the juxtamembrane sequence of the receptor dose-dependently inhibited the binding of Src family tyrosine kinases to the autophosphorylated PDGF alpha-receptor. The mutant receptor showed similar PDGF-induced kinase activity and ability to mediate mitogenicity, actin reorganization and chemotaxis as the wild-type receptor. Thus activation of Src family kinases by the PDGF alpha-receptor is not essential for PDGF-induced mitogenicity or actin reorganization.

摘要

在血小板衍生生长因子α受体(PDGFα受体)近膜区域鉴定出两个新的自磷酸化位点,即酪氨酸-572(Tyr-572)和酪氨酸-574(Tyr-574)。构建了Y572/574F突变型PDGF(α)受体,并在猪主动脉内皮细胞中稳定表达。与野生型受体不同,突变型受体无法与Src家族酪氨酸激酶结合或激活它们。代表受体近膜序列的酪氨酸磷酸化合成肽呈剂量依赖性地抑制Src家族酪氨酸激酶与自磷酸化的PDGFα受体的结合。突变型受体表现出与野生型受体相似的PDGF诱导的激酶活性以及介导有丝分裂、肌动蛋白重组和趋化性的能力。因此,PDGFα受体对Src家族激酶的激活对于PDGF诱导的有丝分裂或肌动蛋白重组并非必不可少。

相似文献

1
PDGF alpha-receptor mediated cellular responses are not dependent on Src family kinases in endothelial cells.血小板衍生生长因子α受体介导的细胞反应在内皮细胞中不依赖于Src家族激酶。
J Cell Sci. 1998 Mar;111 ( Pt 5):607-14. doi: 10.1242/jcs.111.5.607.
2
Mutation of a Src phosphorylation site in the PDGF beta-receptor leads to increased PDGF-stimulated chemotaxis but decreased mitogenesis.血小板衍生生长因子β受体中Src磷酸化位点的突变导致血小板衍生生长因子刺激的趋化性增加,但有丝分裂生成减少。
EMBO J. 1996 Oct 1;15(19):5299-313.
3
Identification of Tyr-762 in the platelet-derived growth factor alpha-receptor as the binding site for Crk proteins.确定血小板衍生生长因子α受体中的酪氨酸762为Crk蛋白的结合位点。
Oncogene. 1998 Mar 12;16(10):1229-39. doi: 10.1038/sj.onc.1201641.
4
Structural determinants in the platelet-derived growth factor alpha-receptor implicated in modulation of chemotaxis.血小板衍生生长因子α受体中涉及趋化性调节的结构决定因素。
J Biol Chem. 1996 Mar 1;271(9):5101-11. doi: 10.1074/jbc.271.9.5101.
5
Identification of two juxtamembrane autophosphorylation sites in the PDGF beta-receptor; involvement in the interaction with Src family tyrosine kinases.血小板衍生生长因子β受体中两个近膜自磷酸化位点的鉴定;与Src家族酪氨酸激酶相互作用的参与情况。
EMBO J. 1993 Jun;12(6):2257-64. doi: 10.1002/j.1460-2075.1993.tb05879.x.
6
STAT activation by the PDGF receptor requires juxtamembrane phosphorylation sites but not Src tyrosine kinase activation.血小板衍生生长因子受体(PDGF受体)介导的信号转导及转录激活蛋白(STAT)激活需要近膜磷酸化位点,但不需要Src酪氨酸激酶激活。
Oncogene. 1999 Jun 17;18(24):3583-92. doi: 10.1038/sj.onc.1202694.
7
A dual inhibitor of platelet-derived growth factor beta-receptor and Src kinase activity potently interferes with motogenic and mitogenic responses to PDGF in vascular smooth muscle cells. A novel candidate for prevention of vascular remodeling.一种血小板衍生生长因子β受体和Src激酶活性的双重抑制剂可有效干扰血管平滑肌细胞中对血小板衍生生长因子的促运动和促有丝分裂反应。一种预防血管重塑的新候选物。
Circ Res. 1999 Jul 9;85(1):12-22. doi: 10.1161/01.res.85.1.12.
8
Src family kinases mediate receptor-stimulated, phosphoinositide 3-kinase-dependent, tyrosine phosphorylation of dual adaptor for phosphotyrosine and 3-phosphoinositides-1 in endothelial and B cell lines.Src家族激酶在内皮细胞系和B细胞系中介导受体刺激的、磷酸肌醇3激酶依赖性的、磷酸酪氨酸和3-磷酸肌醇双重衔接蛋白-1的酪氨酸磷酸化。
J Biol Chem. 2001 Nov 16;276(46):42767-73. doi: 10.1074/jbc.M107194200. Epub 2001 Aug 27.
9
Membrane ruffling and chemotaxis transduced by the PDGF beta-receptor require the binding site for phosphatidylinositol 3' kinase.由血小板衍生生长因子β受体转导的膜 ruffling 和趋化性需要磷脂酰肌醇3'激酶的结合位点。
Oncogene. 1994 Feb;9(2):651-60.
10
Demonstration of functionally different interactions between phospholipase C-gamma and the two types of platelet-derived growth factor receptors.磷脂酶C-γ与两种血小板衍生生长因子受体之间功能不同的相互作用的证明。
J Biol Chem. 1995 Mar 31;270(13):7773-81. doi: 10.1074/jbc.270.13.7773.

引用本文的文献

1
The oncogenic FIP1L1-PDGFRα fusion protein displays skewed signaling properties compared to its wild-type PDGFRα counterpart.与野生型PDGFRα相比,致癌性FIP1L1-PDGFRα融合蛋白表现出信号传导特性的偏差。
JAKSTAT. 2015 Jul 17;4(1):e1062596. doi: 10.1080/21623996.2015.1062596. eCollection 2015.
2
A reactive oxygen species-mediated, self-perpetuating loop persistently activates platelet-derived growth factor receptor α.活性氧物质介导的、自我维持的循环持续激活血小板衍生生长因子受体 α。
Mol Cell Biol. 2014 Jan;34(1):110-22. doi: 10.1128/MCB.00839-13. Epub 2013 Nov 4.
3
Distinct effectors of platelet-derived growth factor receptor-alpha signaling are required for cell survival during embryogenesis.
血小板衍生生长因子受体α信号的不同效应器是胚胎发育过程中细胞存活所必需的。
Proc Natl Acad Sci U S A. 2005 Jun 7;102(23):8233-8. doi: 10.1073/pnas.0502885102. Epub 2005 May 26.
4
Platelet-derived growth factor-dependent association of the GTPase-activating protein of Ras and Src.血小板衍生生长因子依赖的Ras鸟苷三磷酸酶激活蛋白与Src的关联
Biochem J. 1999 Dec 1;344 Pt 2(Pt 2):519-26.
5
Src family kinases are required for integrin but not PDGFR signal transduction.Src家族激酶是整合素信号转导所必需的,但不是血小板衍生生长因子受体(PDGFR)信号转导所必需的。
EMBO J. 1999 May 4;18(9):2459-71. doi: 10.1093/emboj/18.9.2459.
6
Activation of Src family members is not required for the platelet-derived growth factor beta receptor to initiate mitogenesis.血小板衍生生长因子β受体启动有丝分裂并不需要Src家族成员的激活。
Mol Cell Biol. 1998 Apr;18(4):2014-22. doi: 10.1128/MCB.18.4.2014.